Ordinary Discount Solanum Lycopersicum Powder - Epimedium Extract – Chenlv
Ordinary Discount Solanum Lycopersicum Powder - Epimedium Extract – Chenlv Detail:
Active ingredients: icariin, epinedoside A,noricarliin,I-cariresinol
Latin name: epimedium brevicornum maxim, epimedium sagittatum(sieb.et zucc.)maxim
Part used: leaf
Appearance: Brown and yellow powder
Test method: HPLC
Epimedium is a traditional Chinese medicine supplement, which is used to make up the kidney of yang, strengthen the bone, remove the wind and wet wind, and it is used for anopsis, the disruptcy, rheumatism, rheumatism, numbness and contracture and menopausal hypertension. It can effectively inhibit staphylococcus and prevent aging. Epimedium is one of its active ingredients, which can effectively improve cardiac vascular system, adjust endocrine and improve endocrine. In addition, it is of particular concern that the Epimedium has anti-cancer effect and is regarded as the most potential anti-cancer drug.
Product packaging: 25kg/drum
Validity period: 24 months
Product detail pictures:
Related Product Guide:
We'll make every effort and hard work to be superb and excellent, and speed up our steps for standing inside the rank of intercontinental top-grade and high-tech enterprises for Ordinary Discount Solanum Lycopersicum Powder - Epimedium Extract – Chenlv, The product will supply to all over the world, such as: Rwanda , Zambia , Victoria , With a wide range, good quality, reasonable prices and stylish designs, our products are extensively used in this field and other industries. We welcome new and old customers from all walks of life to contact us for future business relationships and achieving mutual success! We welcome customers, business associations and friends from all parts of the world to contact us and seek cooperation for mutual benefits.
By Mark from Mauritania - 2018.02.12 14:52
In China, we have many partners, this company is the most satisfying to us, reliable quality and good credit, it is worth appreciation.
By Kristin from Qatar - 2018.08.12 12:27